Ferroptosis: molecular mechanisms and health implications.

Tang D, Chen X, Kang R, Kroemer G. · 2021

Read Ferroptosis: molecular mechanisms and health implications. by Tang D, Chen X, Kang R, Kroemer G. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8026611.txt.

Introduction

Tang and co-authors review ferroptosis, an iron-dependent form of cell death, and its stakes for health. Ferroptosis was first described in 2012 as non-apoptotic and driven by lipid peroxidation. It starts when oxidants overwhelm antioxidant defenses. Redox-active enzymes sit on both sides of that balance. Regulation reaches from epigenetic marks down to protein modification.

The review lays out two routes into ferroptosis. One depends on transporters, the other on enzymes inside the cell. The transcription factor NFE2L2 anchors the defense against it. Selective autophagy, by contrast, can push cells toward ferroptotic death. The authors then trace what goes wrong in disease. Cancer, neurodegeneration, tissue injury, inflammation, and infection all feature. The synthesis links a young death pathway to wide clinical terrain.

Catalog record

CREATORTang D, Chen X, Kang R, Kroemer G.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE126 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8026611

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Ferroptosis: molecular mechanisms and health implications By Daolin Tang, Xin Chen, Rui Kang, Guido Kroemer Published in: Cell Research DOI: 10.1038/s41422-020-00441-1 ABSTRACT Abstract Cell death can be executed through different subroutines. Since the description of ferroptosis as an iron-dependent form of non-apoptotic cell death in 2012, there has been mounting interest in the process and function of ferroptosis. Ferroptosis can occur through two major pathways, the extrinsic or transporter-dependent pathway and the intrinsic or enzyme-regulated pathway. Ferroptosis is caused by a redox imbalance between the production of oxidants and antioxidants, which is driven by the abnormal expression and activity of multiple redox-active enzymes that produce or detoxify free radicals and lipid oxidation products. Accordingly, ferroptosis is precisely regulated at multiple levels, including epigenetic, transcriptional, posttranscriptional and posttranslational layers. The transcription factor NFE2L2 plays a central role in upregulating anti-ferroptotic defense, whereas selective autophagy may promote ferroptotic death. Here, we review current knowledge on the integrated molecular machinery of ferroptosis and describe how dysregulated ferroptosis is involved in cancer, neurodegeneration, tissue injury, inflammation, and infection. Subject terms: Cell biology, Molecular biology INTRODUCTION Over the past decades, several forms of cell death were identified and classified as accidental or regulated cell deaths.1 Unlike accidental cell death (an uncontrolled passive process), regulated (active) cell death can be mediated through a series of molecular mechanisms and signaling pathways.2 The best-studied form of regulated cell death is apoptosis, which is mainly triggered by the activation of proteases from the caspase family. Non-apoptotic cell death has recently attracted widespread attention in tumor therapy because resistance to apoptosis is a hallmark of cancer. One such non-apoptotic modality of cell death, ferroptosis, is defined as an iron-dependent regulated necrosis that is caused by massive lipid peroxidation-mediated membrane damage.3 The toxicity of iron and lipid peroxidation were reported in the 1900s and 1950s, respectively.4,5 As an evolutionary conservative program, ferroptosis plays a vital role in the development and disease of various organisms, including the plant and animal kingdoms.6,7 Although the term “ferroptosis” was coined in 2012 after screenings for small-molecule compounds capable of inhibiting the growth of RAS-mutant cancer cells8 (Fig. 1), the initial theoretical idea of ferroptosis may have developed from nutrient (in particular cysteine) depletion-induced cancer cell death9 and “oxytosis”, the death of neurons succumbing to the excitotoxin glutamate and simultaneous inhibition of the amino acid antiporter solute carrier family 7 member 11 (SLC7A11/xCT/system xc−).10–12 Recently, multiple pharmacological or natural compounds (Supplementary information, Table S1) and cell-intrinsic proteins (Supplementary information, Table S2) have been reported to regulate the process and function of ferroptotic cell death. Here, we will summarize the emerging regulatory network that affects ferroptosis, as well as its potential pathogenic role in diseases, while emphasizing unresolved questions in this area. [Figure: Timeline of ferroptosis research.A brief history of molecular and pharmacological modulators of ferroptosis.] HALLMARKS OF FERROPTOSIS Morphological features Although an initial study indicated that ferroptosis is morphologically, biochemically and genetically distinct from apoptosis, necrosis and autophagy,8 most investigators concur that cells undergoing ferroptosis usually show necrosis-like morphological changes.13 These features include a loss of plasma membrane integrity, cytoplasmic swelling (oncosis), swelling of cytoplasmic organelles and moderate chromatin condensation. In some cases, ferroptosis is also accompanied by detachment and rounding up of cells, as well as by increased autophagosomes.8,14–16 Of note, ferroptosis occurring in one cell can reportedly spread to adjacent cells in a fast-propagating wave.17,18 At the ultrastructural level, ferroptotic cells usually exhibit mitochondrial abnormalities, such as condensation or swelling, increased membrane density, reduced or absent crista, as well as rupture of the outer membrane.8,15,16 Despite these significant changes in mitochondrial morphology, the role of these organelles in ferroptosis remains controversial. Mitochondria are the center of metabolism and an important source of reactive oxygen species (ROS) in most mammalian cells. At odds with an early study indicating that mitochondria-mediated ROS production is not necessary for ferroptosis,8 more recent evidence indicates that mitochondrion-mediated ROS production, DNA stress, and metabolic reprogramming are required for lipid peroxidation and ferroptosis induction.19–21 Biochemical features Ferroptosis is a ROS-dependent form of cell death associated with two main biochemical characteristics, namely iron accumulation and lipid peroxidation (Fig. 2). [Figure: Core molecular machinery and signaling regulation of ferroptosis.Ferroptosis can occur through two major pathways, the extrinsic or transporter-dependent pathway (e.g., decreased cysteine or glutamine uptake and increased iron uptake), and the intrinsic or enzyme-regulated pathway (e.g., the inhibition of GPX4).] Iron accumulation The classical ferroptosis activators erastin or RSL3 inhibit the antioxidant system as they increase intracellular iron accumulation.8 Iron may directly generate excessive ROS through the Fenton reaction, thereby increasing oxidative damage.8 In addition, iron may increase the activity of lipoxygenase (ALOX) or EGLN prolyl hydroxylases (also called PHD), which are enzymes responsible for lipid peroxidation and oxygen homeostasis. The dynamics between systemic and local cellular iron regulation affects the sensitivity of ferroptosis.22 Targeting genes related to iron overload, or the use of iron-chelating agents, effectively inhibits ferroptotic cell death (discussed later). It is unclear why only iron, but not other metals (such as zinc) that also cause ROS production through a Fenton reaction,23 has the ability to induce ferroptosis.8 One possibility is that iron overload activates specific downstream effectors that contribute to the execution of ferroptosis after the production of lipid ROS. Lipid peroxidation Lipid peroxidation is a free radical-driven reaction, which mainly affects unsaturated fatty acids in the cell membrane. The products of lipid peroxidation include the initial lipid hydroperoxides (LOOHs) and subsequent reactive aldehydes (e.g., malondialdehyde (MDA) and 4-hydroxynonenal (4HNE)), which increase during ferroptosis. There are three types of fatty acids, namely, saturated fatty acids (no double bond), monounsaturated fatty acids (MUFAs, 1 double bond) and polyunsaturated fatty acids (PUFAs, >1 double bond). Although various cell membrane lipids (e.g., phosphatidylcholine, phosphatidylethanolamine (PE) and cardiolipin) may be oxidized, peroxidation of PUFAs in phospholipids by ALOXs appears to be particularly important for ferroptosis.24,25 Although mitochondria undergo strong changes during ferroptosis, cardiolipin peroxidation is not found in ferroptosis.26 Genetic features The overexpression of a few genes/proteins has been considered a biomarker of ferroptosis, as exemplified by prostaglandin-endoperoxide synthase 2 (PTGS2/COX2), the key enzyme in prostaglandin biosynthesis.27 However, PTGS2 does not use prostaglandins as a substrate for lipid peroxidation in ferroptosis. Acyl-CoA synthetase long-chain family member 4 (ACSL4), an enzyme involved in fatty acid metabolism, is considered as a specific biomarker and driver of ferroptosis because the upregulation of ACSL4 enhances the PUFA content in phospholipids, which are susceptible to oxidation reactions leading to ferroptosis.24,28,29 Nonetheless, ACSL4 is not required for ferroptosis in all cases, meaning ACSL4-depleted cells can undergo ferroptosis in specific circumstances.30 The activation of genes responsible for antioxidant defense (e.g., the glutathione (GSH) system,8 coenzyme Q10 (CoQ10) system,31,32 and the nuclear factor, erythroid 2-like 2 (NFE2L2, also known as NRF2) transcription pathway33) and membrane repair (e.g., the endosomal sorting complexes required for transport (ESCRT)-III pathway34) limit membrane damage during ferroptosis (Fig. 2). Thus, depending on the balance of injury and anti-injury responses, cells “decide” to live or to die in response to ferroptotic stimuli. Immune features The immunological consequences of ferroptosis involve two aspects. First, ferroptosis can lead to the death of leukocyte subsets and the corresponding loss of immune function. For example, lipid peroxidation-induced ferroptosis in T cells

Read the complete text